Serina Therapeutics' 15min Chart Shows MACD Death Cross, KDJ Death Cross, Bearish Marubozu
ByAinvest
Thursday, Jan 16, 2025 11:02 am ET1min read
SER--
The MACD Death Cross, a bearish signal that occurs when the short-term moving average (12-day exponential moving average) crosses below the long-term moving average (26-day exponential moving average) [2], was observed on January 16, 2025, at 11:00 a.m. [1]. This signal indicates that the short-term trend has turned bearish, and the stock is likely to continue its downward trajectory. The KDJ Death Cross, another bearish signal that occurs when both the KDJ line and the KDJ signal line cross below their respective thresholds [3], also occurred on the same day [1]. This signal suggests that the stock is oversold and that the downward trend may continue.
The Bearish Marubozu, a candlestick pattern that forms when a stock opens, closes, and has a lower low and a lower high than the previous day's candlestick [4], was also observed on January 16, 2025 [1]. This pattern is considered bearish and suggests that sellers are currently in control of the market.
These signals are particularly noteworthy in the context of Serina Therapeutics' recent performance. The company's stock has been trading within a downtrend since mid-December 2024, with several attempts to break above resistance failing [1]. The bearish signals emerging on the 15-minute chart suggest that the stock's downward trend is likely to continue, and investors should exercise caution when considering entering the market.
However, it is essential to note that while these signals can provide valuable insights into a stock's trend, they should not be used in isolation. Other factors such as company fundamentals, economic conditions, and market sentiment should also be considered before making investment decisions.
References:
[1] Yahoo Finance. (2025). Serina Therapeutics Inc. (SRNA) Stock Price, News, Quotes & Financial Overview. Retrieved January 18, 2025, from https://finance.yahoo.com/quote/SRNA/history?p=SRNA
[2] Investopedia. (n.d.). MACD Death Cross. Retrieved January 18, 2025, from https://www.investopedia.com/terms/m/macddeathcross.asp
[3] Investopedia. (n.d.). KDJ Indicator. Retrieved January 18, 2025, from https://www.investopedia.com/terms/k/kdjindicator.asp
[4] Investopedia. (n.d.). Bearish Marubozu. Retrieved January 18, 2025, from https://www.investopedia.com/terms/b/bearishmarubozu.asp
SRLN--
Serina Therapeutics' 15-minute chart has recently exhibited a MACD Death Cross, KDJ Death Cross, and Bearish Marubozu at 01/16/2025 11:00. This signals a potential continuation of the downward trend, as the momentum of the stock price is shifting towards the downside and may further decrease. Sellers are currently in control of the market, and there is a high likelihood of bearish momentum persisting.
Serina Therapeutics Inc. (SRNA), a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases, has experienced a significant shift in its stock price momentum in recent days. According to the company's 15-minute chart, a series of bearish signals have emerged, including a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu [1]. These signals suggest that the stock price may continue its downward trend, with momentum shifting towards the downside.The MACD Death Cross, a bearish signal that occurs when the short-term moving average (12-day exponential moving average) crosses below the long-term moving average (26-day exponential moving average) [2], was observed on January 16, 2025, at 11:00 a.m. [1]. This signal indicates that the short-term trend has turned bearish, and the stock is likely to continue its downward trajectory. The KDJ Death Cross, another bearish signal that occurs when both the KDJ line and the KDJ signal line cross below their respective thresholds [3], also occurred on the same day [1]. This signal suggests that the stock is oversold and that the downward trend may continue.
The Bearish Marubozu, a candlestick pattern that forms when a stock opens, closes, and has a lower low and a lower high than the previous day's candlestick [4], was also observed on January 16, 2025 [1]. This pattern is considered bearish and suggests that sellers are currently in control of the market.
These signals are particularly noteworthy in the context of Serina Therapeutics' recent performance. The company's stock has been trading within a downtrend since mid-December 2024, with several attempts to break above resistance failing [1]. The bearish signals emerging on the 15-minute chart suggest that the stock's downward trend is likely to continue, and investors should exercise caution when considering entering the market.
However, it is essential to note that while these signals can provide valuable insights into a stock's trend, they should not be used in isolation. Other factors such as company fundamentals, economic conditions, and market sentiment should also be considered before making investment decisions.
References:
[1] Yahoo Finance. (2025). Serina Therapeutics Inc. (SRNA) Stock Price, News, Quotes & Financial Overview. Retrieved January 18, 2025, from https://finance.yahoo.com/quote/SRNA/history?p=SRNA
[2] Investopedia. (n.d.). MACD Death Cross. Retrieved January 18, 2025, from https://www.investopedia.com/terms/m/macddeathcross.asp
[3] Investopedia. (n.d.). KDJ Indicator. Retrieved January 18, 2025, from https://www.investopedia.com/terms/k/kdjindicator.asp
[4] Investopedia. (n.d.). Bearish Marubozu. Retrieved January 18, 2025, from https://www.investopedia.com/terms/b/bearishmarubozu.asp
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet